tradingkey.logo

tradingkey.logo
怜玢


Bruker Corp

BRKR
りォッチリストに远加
60.525USD
-2.525-4.00%
取匕時間 09/18, 15:02ET
9.22B時䟡総額
損倱額盎近12ヶ月PER

詳现情報 Bruker Corp 䌁業名

Bruker Corporation is a developer, manufacturer and distributor of high-performance scientific instruments and analytical and diagnostic. Its segments include Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies (BEST). BSI segment designs, manufactures and distributes life science tools based on magnetic resonance technology and offers automated laboratory research. BSI CALID segment designs, manufactures and distributes life science mass spectrometry, applied spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. BSI NANO designs, manufactures and distributes advanced x-ray instruments, atomic force microscopy instrumentation, and fluorescence optical microscopy instruments. BEST segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and energy physics research.

Bruker Corp プロフィヌル


䌁業コヌドBRKR
䌚瀟名Bruker Corp
䞊堎日Aug 04, 2000
最高経営責任者「CEO」Prause (Burkhard A)
埓業員数11396
蚌刞皮類Ordinary Share
決算期末Aug 04
本瀟所圚地40 Manning Rd
郜垂BILLERICA
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号01821-3915
電話番号19786633660
りェブサむトhttps://www.bruker.com/
䌁業コヌドBRKR
䞊堎日Aug 04, 2000
最高経営責任者「CEO」Prause (Burkhard A)

Bruker Corpの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Frank H. Laukien, Ph.D.
Dr. Frank H. Laukien, Ph.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
40.42M
+0.03%
Dr. Frank H. Laukien, Ph.D.
Dr. Frank H. Laukien, Ph.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
40.42M
+0.03%
Dr. Frank H. Laukien, Ph.D.
Dr. Frank H. Laukien, Ph.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
40.42M
+0.03%
Dr. Mark Robert Munch, Ph.D.
Dr. Mark Robert Munch, Ph.D.
Executive Vice President, President of Bruker NANO Group
Executive Vice President, President of Bruker NANO Group
90.51K
+7.03%
Dr. Mark Robert Munch, Ph.D.
Dr. Mark Robert Munch, Ph.D.
Executive Vice President, President of Bruker NANO Group
Executive Vice President, President of Bruker NANO Group
90.51K
+7.03%
Dr. Mark Robert Munch, Ph.D.
Dr. Mark Robert Munch, Ph.D.
Executive Vice President, President of Bruker NANO Group
Executive Vice President, President of Bruker NANO Group
90.51K
+7.03%
Mr. Richard A. Packer
Mr. Richard A. Packer
Lead Independent Director
Lead Independent Director
89.17K
-1.37%
Mr. Richard A. Packer
Mr. Richard A. Packer
Lead Independent Director
Lead Independent Director
89.17K
-1.37%
Mr. Richard A. Packer
Mr. Richard A. Packer
Lead Independent Director
Lead Independent Director
89.17K
-1.37%
Mr. Gerald N. Herman
Mr. Gerald N. Herman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
64.97K
+13.50%
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Frank H. Laukien, Ph.D.
Dr. Frank H. Laukien, Ph.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
40.42M
+0.03%
Dr. Frank H. Laukien, Ph.D.
Dr. Frank H. Laukien, Ph.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
40.42M
+0.03%
Dr. Frank H. Laukien, Ph.D.
Dr. Frank H. Laukien, Ph.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
40.42M
+0.03%
Dr. Mark Robert Munch, Ph.D.
Dr. Mark Robert Munch, Ph.D.
Executive Vice President, President of Bruker NANO Group
Executive Vice President, President of Bruker NANO Group
90.51K
+7.03%
Dr. Mark Robert Munch, Ph.D.
Dr. Mark Robert Munch, Ph.D.
Executive Vice President, President of Bruker NANO Group
Executive Vice President, President of Bruker NANO Group
90.51K
+7.03%
Dr. Mark Robert Munch, Ph.D.
Dr. Mark Robert Munch, Ph.D.
Executive Vice President, President of Bruker NANO Group
Executive Vice President, President of Bruker NANO Group
90.51K
+7.03%

よくある質問

Bruker Corpの䞊䜍5名の株䞻は誰ですか


Bruker Corpの䞊䜍5名の株䞻は以䞋のずおりです。Dr. Frank H. Laukien, Ph.D.

Bruker CorpBRKRの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Bruker Corpの株匏を保有しおいる機関は929瀟あり、保有株匏の総垂堎䟡倀は玄139.65Mで、党䜓の91.74%を占めおいたす。2025Q4ず比范しお、機関の持ち株は-14820228.00増加しおいたす。

Bruker Corpの最倧の収益源は䜕ですか


2026Q1においお、Product郚門がBruker Corpにずっお最倧の収益を生み出しおおり、その金額は663.70Mで、党収益の79.15%を占めおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。